Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: OPHIREX, INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-06-19 to 2023-09-29
Current total value of award: $10571594
Description: TARGETING SPLA2 FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME ASSOCIATED WITH SARS-COV-2